Medical/Pharmaceuticals
Assure Family Clinic - An Integrative GP Clinic That Aims To Enhance Your Physical And Mental Wellbeing
The one-stop clinic located in Bukit Merah Central offers a full range of GP services for adults and children, as well as health and wellness screening. SINGAPORE, Sept. 8, 2023 /PRNewswire/ -- Based on the principles of integrative medicine, Assure Family Clinic takes the 'whole person' approach...
2023-09-08 11:30
1621
Adagene to Present at Investor and Scientific Conferences in September
- Adagene's CEO and President of R&D, Dr. Peter Luo, participating in SITC webinar onSeptember 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies - SAN DIEGO and SUZHOU, China, Sept. 8, 2023 /PRNewswire/ -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a platform-driven, clinic...
2023-09-08 10:45
1696
World Orphan Drug Alliance Welcomes Specialised Therapeutics
* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...
2023-09-08 04:00
1447
United Imaging Confirms Installation of Country's First uMI Panorama™ at Huntsman Cancer Institute
The award-winning 12-year old manufacturer and widely-recognized leading cancer center agreed to install United Imaging's recently unveiled innovation. HOUSTON, Texas, Sept. 7, 2023 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced t...
2023-09-07 21:00
1264
SOAP Health and AESOP Technology Unite to Provide Advanced AI Solutions for Clinical Decision-Support and Medical Coding
SOAP Health's conversational AI for medical encounters, risk and symptom assessment, and documentation integrates with AESOP Technology's electronic medical record data analysis for clinical decision optimization, coding, and productivity. BOCA RATON, Fla., Sept. 7, 2023 /PRNewswire/ -- SOAP Hea...
2023-09-07 21:00
1337
Australian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE™ Award for Duchenne Muscular Dystrophy
- Grant funding will support Save our Sons Duchenne Foundation in developing a digital health app - SYDNEY, Sept. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that an Australian patient advocacy organization is one of the two recipients of the company's 2023 STRI...
2023-09-07 20:00
1590
Clarius Applauded by Frost & Sullivan with the Company of the Year Award for Its Handheld Ultrasound Systems and Market-leading Position
Clarius has become a notable player in the industry with the ability to deliver exceptional hospital-grade performance cost-effectively. SAN ANTONIO, Sept. 7, 2023 /PRNewswire/ -- Recently, Frost & Sullivan assessed the ultraportable ultrasound industry and, based on its findings, recognizesClar...
2023-09-07 20:00
1310
TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in Neurological Care and Its Market-leading Position
TeraRecon partners with different vendors to provide precise, AI-supported patient care and expand in the neurological solutions market and other disease areas, improving patient outcomes. SAN ANTONIO, Sept. 7, 2023 /PRNewswire/ -- Recently, Frost & Sullivan researched the AI-based neurological ...
2023-09-07 20:00
1379
World Health Summit 2023 with 20 ministers from all over the world in Berlin from October 15-17
Press accreditation open for the world's leading global health conference BERLIN, Sept. 7, 2023 /PRNewswire/ -- The World Health Summit 2023 from October 15-17 in Berlin will bring together the most prominent names in global health from all sectors in all regions of the world. Speakers will inclu...
2023-09-07 19:16
1255
The 2nd Global ADC and XDC Innovation Conference will be held in Wuxi in September
SHANGHAI, Sept. 7, 2023 /PRNewswire/ -- The 2nd Global ADC and XDC Innovation
Conference (Global XDC 2023) will be held in Wuxi,China on Sept 21st-22nd, 2023
. The conference is supported by Wuxi High-tech Zone Administrative Committee,
WuXi Biologics, Wuxi XDC, and BioValley.
2023-09-07 17:25
1479
Untangling the enigma of PCOS and its distressing impacts in 12 per cent of women
ADELAIDE, Australia, Sept. 7, 2023 /PRNewswire/ -- Psychological issues including anxiety, depression and negative body image are adding to the physical burden of polycystic ovary syndrome (PCOS), a hormonal disorder that affects 12 per cent of women globally. International research has reveal...
2023-09-07 09:36
1889
Imaging Endpoints Appoints Manish Sharma, MD as Chief Scientific Officer
SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment ofManish Sharma, MD as its Chief Scientific Officer. Dr Sharma, a radiologist with over...
2023-09-06 21:00
1817
Isotopia Issues a call to action to the radionuclide Therapy industry.
PETAH TIKVA, Israel, Sept. 6, 2023 /PRNewswire/ -- Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceutical...
2023-09-06 20:40
1466
Health In Tech Introduces New Ancillary Products to Expand Healthcare Solutions
Expands Health Care offerings with Critical Illness, Accident, Dental, Vision, Term Life, and Gap coverage options. STUART, Fla., Sept. 6, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is e...
2023-09-06 20:30
1380
Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty Surgery.
SAN JOSE, Sept. 6, 2023 /PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced positive topline results from its Phase 2 proof of concept study of TPU-006, a 4-day dexmedetomidine transdermal patch for Post Surgical Pain. The double-blind, placebo-controlled, single-...
2023-09-06 20:06
1896
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 6, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment o...
2023-09-06 20:00
1182
Metabolon Achieves "Great Place To Work"® Certification
Independent survey validates that Metabolon employees are highly invested in the company's mission, growth, and technology MORRISVILLE, N.C., Sept. 6, 2023 /PRNewswire/ -- Metabolon, Inc. is proud to be certified by Great Place To Work®. The prestigious certification is based entirely on curren...
2023-09-06 19:57
1389
Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer
* The first and only anti-PD-1 antibody approved for treating cervical cancer inChina * ORR of 27.8%, mPFS of 3.7m, and mOS of 16.8m achieved as monotherapy with best-in-class potential * A Phase 3 trial (VICT-004) of zimberelimab in combination with platinum-based chemotherapy +/- bevacizu...
2023-09-06 19:00
1204
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule
BRIDGEWATER, N.J. and BENGALURU, India, Sept. 6, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the Company has completed the integration of the acquired biosimilars business from Viatris inNorth America (United St...
2023-09-06 19:00
1425
Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B
BRII-179 (VBI-2601) as an add-on therapy to standard of care PEG-IFNα increases HBsAg loss rate at the end of treatment and 12 weeks follow up Significantly increased HBsAg seroconversion rate is strongly associated with BRII-179 treatment and correlates with the increased rate of HBsAg loss Saf...
2023-09-06 18:45
2000
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 256 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 251 media titles]
2024-04-30 15:13Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2938
